Paper24254084
Secreted heat shock protein gp96-Ig: next-generation vaccines for cancer and infectious diseases.
Strbo N and 3 others. Immunol Res, 2013. Cited by 29 papers, by iCite.
Cite this record
ConductScience Library. Secreted heat shock protein gp96-Ig: next-generation vaccines for cancer and infectious diseases. Papers, record 24254084. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/24254084
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Immunoglobulin Fc Fragments | Major topic |
| Immunoglobulin G | Major topic |
| Membrane Glycoproteins | Major topic |
| Vaccines, Synthetic | Major topic |
| Animals | |
| Antigen-Presenting Cells | |
| Communicable Disease Control | |
| Communicable Diseases | |
| Humans | |
| Immunotherapy | |
| Mucous Membrane | |
| Neoplasms |
Source PubMed
Grants5
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| 1KL2TR000461 | NCATS NIH HHS | United States | KL2TR000461 | PubMed and NIH | NIH RePORTER |
| NCATS NIHUL1TR000460 | NCATS NIH HHS | United States | PubMed | PubMed | |
| NIAID R33 AI073234 | PHS HHS | United States | PubMed | PubMed | |
| NIHP30A1073961 | PHS HHS | United States | PubMed | PubMed | |
| UL1TR000460 | NIH | NIH RePORTER |
References127
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 16181335 | Cross-presentation: underlying mechanisms and role in immune surveillance. | Immunol Rev | 2005 | https://conductscience.org/library/papers/16181335 | PubMed |
| 2 | 12747768 | Determinants of efficacy of immunotherapy with tumor-derived heat shock protein gp96. | Cancer Immun | 2001 | https://conductscience.org/library/papers/12747768 | PubMed |
| 3 | 16772370 | The N-terminal fragment of GRP94 is sufficient for peptide presentation via professional antigen-presenting cells. | Int Immunol | 2006 | https://conductscience.org/library/papers/16772370 | PubMed |
| 4 | 15073331 | Essential role of CD91 in re-presentation of gp96-chaperoned peptides. | Proc Natl Acad Sci U S A | 2004 | https://conductscience.org/library/papers/15073331 | PubMed |
| 5 | 18602688 | An adjuvant autologous therapeutic vaccine (HSPPC-96; vitespen) versus observation alone for patients at high risk of recurrence after nephrectomy for renal cell carcinoma: a multicentre, open-label, randomised phase III trial. | Lancet | 2008 | https://conductscience.org/library/papers/18602688 | PubMed |
| 6 | 17133412 | Experience with heat shock protein-peptide complex 96 vaccine therapy in patients with indolent non-Hodgkin lymphoma. | Cancer | 2007 | https://conductscience.org/library/papers/17133412 | PubMed |
| 7 | 8344253 | Tumor rejection antigen gp96/grp94 is an ATPase: implications for protein folding and antigen presentation. | EMBO J | 1993 | https://conductscience.org/library/papers/8344253 | PubMed |
| 8 | 1803416 | Heat shock and development. Introduction. | Results Probl Cell Differ | 1991 | https://conductscience.org/library/papers/1803416 | PubMed |
| 9 | 23050124 | HSP70 and HSP90 Differentially Regulate Translocation of Extracellular Antigen to the Cytosol for Cross-Presentation. | Autoimmune Dis | 2012 | https://conductscience.org/library/papers/23050124 | PubMed |
| 10 | 11584270 | Endoplasmic reticulum chaperone gp96 is required for innate immunity but not cell viability. | Nat Cell Biol | 2001 | https://conductscience.org/library/papers/11584270 | PubMed |
| 11 | 8376942 | Heat shock protein 70-associated peptides elicit specific cancer immunity. | J Exp Med | 1993 | https://conductscience.org/library/papers/8376942 | PubMed |
| 12 | 11884472 | Heat shock proteins gp96 and hsp70 activate the release of nitric oxide by APCs. | J Immunol | 2002 | https://conductscience.org/library/papers/11884472 | PubMed |
| 13 | 8276462 | Heat shock proteins transfer peptides during antigen processing and CTL priming. | Immunogenetics | 1994 | https://conductscience.org/library/papers/8276462 | PubMed |
| 14 | 9973383 | Isolation of MHC class I-restricted tumor antigen peptide and its precursors associated with heat shock proteins hsp70, hsp90, and gp96. | J Immunol | 1999 | https://conductscience.org/library/papers/9973383 | PubMed |
| 15 | 22956587 | T cell costimulation by TNFR superfamily (TNFRSF)4 and TNFRSF25 in the context of vaccination. | J Immunol | 2012 | https://conductscience.org/library/papers/22956587 | PubMed |
| 16 | 21965338 | Insight into the heterogeneity of breast cancer through next-generation sequencing. | J Clin Invest | 2011 | https://conductscience.org/library/papers/21965338 | PubMed |
| 17 | 19079181 | Protective attenuated lentivirus immunization induces SIV-specific T cells in the genital tract of rhesus monkeys. | Mucosal Immunol | 2008 | https://conductscience.org/library/papers/19079181 | PubMed |
| 18 | 11086034 | Cutting edge: heat shock protein gp96 induces maturation and migration of CD11c+ cells in vivo. | J Immunol | 2000 | https://conductscience.org/library/papers/11086034 | PubMed |
| 19 | 18362942 | Vaccination of metastatic renal cell carcinoma patients with autologous tumour-derived vitespen vaccine: clinical findings. | Br J Cancer | 2008 | https://conductscience.org/library/papers/18362942 | PubMed |
| 20 | 11170476 | Biophysical analysis of the endoplasmic reticulum-resident chaperone/heat shock protein gp96/GRP94 and its complex with peptide antigen. | Biochemistry | 2001 | https://conductscience.org/library/papers/11170476 | PubMed |
Cited by23
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 29 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42194790 | Narrative Review of Potential Non-Surgical Treatments for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer. | J Clin Med | 2026 | https://conductscience.org/library/papers/42194790 | PubMed |
| 41970953 | Heat shock protein Gp96 (Grp94) in malaria: functional insights at the host-parasite interface and therapeutic perspectives. | Front Cell Dev Biol | 2026 | https://conductscience.org/library/papers/41970953 | PubMed |
| 39339992 | Immunometabolic Regulation of Vaccine-Induced Antibody Responses in Aging Mice. | Vaccines (Basel) | 2024 | https://conductscience.org/library/papers/39339992 | PubMed |
| 39148727 | HSP90 multi-functionality in cancer. | Front Immunol | 2024 | https://conductscience.org/library/papers/39148727 | PubMed |
| 38201276 | "All for One and One for All": The Secreted Heat Shock Protein gp96-Ig Based Vaccines. | Cells | 2023 | https://conductscience.org/library/papers/38201276 | PubMed |
| 37056783 | Induction of antigen specific intrahepatic CD8+ T cell responses by a secreted heat shock protein based gp96-Ig-PfCA malaria vaccine. | Front Immunol | 2023 | https://conductscience.org/library/papers/37056783 | PubMed |
| 36358853 | Targeting Heat Shock Proteins in Malignant Brain Tumors: From Basic Research to Clinical Trials. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/36358853 | PubMed |
| 35936992 | Secreted heat shock protein gp96-Ig and OX40L-Fc combination vaccine enhances SARS-CoV-2 Spike (S) protein-specific B and T cell immune responses. | Vaccine X | 2022 | https://conductscience.org/library/papers/35936992 | PubMed |
| 35717566 | Ex vivo Optimization of Glucose-Regulated Protein 94/Glycoprotein 96 Expressions in Mammospheres; Implication for Breast Cancer Immunotherapy. | Cell J | 2022 | https://conductscience.org/library/papers/35717566 | PubMed |
| 34536241 | Secretion of a low-molecular-weight species of endogenous GRP94 devoid of the KDEL motif during endoplasmic reticulum stress in Chinese hamster ovary cells. | Traffic | 2021 | https://conductscience.org/library/papers/34536241 | PubMed |
| 33584668 | Induction of SARS-CoV-2 Protein S-Specific CD8+ T Cells in the Lungs of gp96-Ig-S Vaccinated Mice. | Front Immunol | 2020 | https://conductscience.org/library/papers/33584668 | PubMed |
| 33421475 | Recombinant protein vaccines, a proven approach against coronavirus pandemics. | Adv Drug Deliv Rev | 2021 | https://conductscience.org/library/papers/33421475 | PubMed |
| 32793245 | The Long Road Toward COVID-19 Herd Immunity: Vaccine Platform Technologies and Mass Immunization Strategies. | Front Immunol | 2020 | https://conductscience.org/library/papers/32793245 | PubMed |
| 31963413 | Immunosurveillance and Immunoediting of Lung Cancer: Current Perspectives and Challenges. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/31963413 | PubMed |
| 30703157 | Dendritic cells pulsed with placental gp96 promote tumor-reactive immune responses. | PLoS One | 2019 | https://conductscience.org/library/papers/30703157 | PubMed |
| 30656066 | Application of built-in adjuvants for epitope-based vaccines. | PeerJ | 2019 | https://conductscience.org/library/papers/30656066 | PubMed |
| 30291897 | Protein-based nanoparticles in cancer vaccine development. | Nanomedicine | 2019 | https://conductscience.org/library/papers/30291897 | PubMed |
| 28857666 | Cancer vaccines: Enhanced immunogenic modulation through therapeutic combinations. | Hum Vaccin Immunother | 2017 | https://conductscience.org/library/papers/28857666 | PubMed |
| 28778250 | Current clinical trials in non-muscle invasive bladder cancer. | Urol Oncol | 2017 | https://conductscience.org/library/papers/28778250 | PubMed |
| 27874054 | Combinational Immunotherapy with Allo-DRibble Vaccines and Anti-OX40 Co-Stimulation Leads to Generation of Cross-Reactive Effector T Cells and Tumor Regression. | Sci Rep | 2016 | https://conductscience.org/library/papers/27874054 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD8A | 925 | PubTator's text mining | https://conductscience.org/library/genes/925 | NCBI Gene |
| HSP90B1 | 7184 | PubTator's text mining | https://conductscience.org/library/genes/7184 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/24254084
GET https://conductscience.org/api/papers/v1/24254084/references?page=2